Odell LR

A Base‐Free, Low Temperature Click and Release Reaction for the In Situ Generation of Diazomethane

Schembri LS, Olaniran E, Söderström M, Skillinghaug B, Odell LR

Adv. Synth. Catal. 365 (11) 1839-1845 [2023-06-13; online 2023-05-23]

Spatial Mass Spectrometry [Service]

On-Tissue Chemical Derivatization for Comprehensive Mapping of Brain Carboxyl and Aldehyde Metabolites by MALDI-MS Imaging.

Kaya I, Schembri LS, Nilsson A, ..., Odell LR, Andrén PE

J. Am. Soc. Mass Spectrom. 34 (5) 836-846 [2023-05-03; online 2023-04-13]

Spatial Mass Spectrometry [Technology development]

Region-Specific and Age-Dependent Multitarget Effects of Acetylcholinesterase Inhibitor Tacrine on Comprehensive Neurotransmitter Systems.

Fridjonsdottir E, Vallianatou T, Mantas I, ..., Svenningsson P, Andrén PE

ACS Chem. Biol. 17 (1) 147-158 [2022-01-21; online 2021-12-21]

Spatial Mass Spectrometry [Technology development]

Mass spectrometry imaging identifies abnormally elevated brain l-DOPA levels and extrastriatal monoaminergic dysregulation in l-DOPA-induced dyskinesia.

Fridjonsdottir E, Shariatgorji R, Nilsson A, ..., Bezard E, Andrén PE

Sci Adv 7 (2) - [2021-01-00; online 2021-01-06]

Spatial Mass Spectrometry [Technology development]

Rational Design of Azastatin as a Potential ADC Payload with Reduced Bystander Killing.

Hartmann RW, Fahrner R, Shevshenko D, ..., Lehmann F, Odell LR

ChemMedChem 15 (24) 2500-2512 [2020-12-15; online 2020-10-16]

Drug Discovery and Development (DDD)

Comprehensive mapping of neurotransmitter networks by MALDI-MS imaging.

Shariatgorji M, Nilsson A, Fridjonsdottir E, ..., Odell LR, Andrén PE

Nat. Methods 16 (10) 1021-1028 [2019-10-00; online 2019-09-23]

Spatial Mass Spectrometry [Technology development]